外科理论与实践

外科理论与实践 >

2026 , Vol. 31 >Issue 02: 121 - 128

DOI: https://doi.org/10.16139/j.1007-9610.2026.02.05

论著

腹腔镜胃袖状切除联合双通道术与腹腔镜胃袖状切除术治疗超级肥胖的近期疗效对比研究

  • 朱玉喜 ,
  • 倪良晨 ,
  • 王键 ,
  • 洪健 ,
  • 朱孝成 ,
  • 姚立彬
展开
  • 1 徐州医科大学附属医院减重代谢外科， 江苏 徐州 221006
    2 徐州医科大学国际肥胖及代谢病中心， 江苏 徐州 221004
作者贡献/Authors’ contributions

朱玉喜、倪良晨、王键负责资料的收集、数据分析和撰写；王键、洪健负责整理数据和汇总；朱孝成、姚立彬负责指导、审查和修订。所有作者均阅读并确认最终稿。

姚立彬，E-mail: yaolibin_123@126.com; 朱孝成，E-mail: zhuxccf@163.com

收稿日期: 2025-05-05

  网络出版日期: 2026-06-23

基金资助

江苏省高水平医院建设项目徐州医科大学附属医院高水平医院建设专项(GSPJS202405);徐州医科大学附属医院高层次科研项目培育计划（重点项目）(PYJH2025202)

收起

Short-term efficacy of laparoscopic sleeve gastrectomy with transit bipartition versus laparoscopic sleeve gastrectomy in the treatment of super obesity

  • ZHU Yuxi ,
  • NI Liangchen ,
  • WANG Jian ,
  • HONG Jian ,
  • ZHU Xiaocheng ,
  • YAO Libin
Expand
  • 1 Department of Bariatric and Metabolic Surgery, the Affiliated Hospital of Xuzhou Medical University, Jiangsu Xuzhou 221006, China
    2 International Center for Obesity and Metabolic Diseases, Xuzhou Medical University, Jiangsu Xuzhou 221004, China

Received date: 2025-05-05

  Online published: 2026-06-23

Fold

摘要

目的：比较腹腔镜胃袖状切除联合双通道术（LSG-TB）与腹腔镜胃袖状切除术（LSG）治疗超级肥胖病人的近期疗效及安全性。方法：回顾分析113例超级肥胖病人（LSG组75例，LSG-TB组38例）术后12个月的减重、代谢改善、营养变化及并发症发生情况。结果：LSG-TB组术后12个月总体重减少百分比(TWL%)和多余体重减少百分比(EWL%)显著高于LSG组（40.0%比36.6%，73.4%比66.2%，P<0.05）。两组血糖控制相当，但LSG-TB组总胆固醇(TC)、低密度脂蛋白(LDL)及尿酸(UA)下降更明显（P<0.05）。胃食管反流病(GERD)缓解率在LSG-TB组亦更高（P<0.05）。两组术后并发症发生率低，营养指标整体稳定。结论：LSG-TB在超级肥胖病人中展现出更优的近期减重与代谢改善效果，且安全性良好，与LSG相当，具有一定的临床应用价值。

关键词： 超级肥胖; 腹腔镜胃袖状切除术; 双通道术; 减重手术; 代谢改善

本文引用格式

朱玉喜 , 倪良晨 , 王键 , 洪健 , 朱孝成 , 姚立彬 . 腹腔镜胃袖状切除联合双通道术与腹腔镜胃袖状切除术治疗超级肥胖的近期疗效对比研究[J]. 外科理论与实践, 2026 , 31(02) : 121 -128 . DOI: 10.16139/j.1007-9610.2026.02.05

Abstract

Objective To compare the short-term efficacy and safety of laparoscopic sleeve gastrectomy (LSG) with transit bipartition (TB) versus LSG in super obese patients. Methods A retrospective study was conducted on 113 super obese patients (LSG 75, LSG-TB 38 cases), evaluating weight loss, metabolic outcomes, nutritional indicators, and complications over 12 months. Results At 12 months, LSG-TB showed significantly higher percentage of total weight loss (%TWL) and percentage of excess weight loss (%EWL) than LSG (40.0% vs. 36.6%, 73.4% vs. 66.2%, P<0.05). Both groups achieved similar glycemic control, while total cholesterol (TC), low density lipoprotein (LDL), and uric acid (UA) levels decreased more in the LSG-TB group (P<0.05). Gastroesophageal reflux disease (GERD) remission was significantly better with LSG-TB (P<0.05). Postoperative complication rates were low in both groups, with stable nutritional status. Conclusions LSG-TB demonstrates superior short-term weight loss and metabolic benefits in super obese patients, with comparable safety to LSG, supporting its clinical value.

Key words： Super obesity; Laparoscopic sleeve gastrectomy (LSG); Transit bipartition(TB); Bariatric surgery; Metabolic benefit

参考文献

[1] SANTO M A, RICCIOPPO D, PAJECKI D, et al. Pre-operative weight loss in super-obese patients: study of the rate of weight loss and its effects on surgical morbidity[J]. Clinics (Sao Paulo), 2014, 69(12):828-834.
[2] HRUBY A, MANSON J E, QI L, et al. Determinants and consequences of obesity[J]. Am J Public Health, 2016, 106(9):1656-1662.
[3] 邢颖, 闫文貌, 白日星. 腹腔镜下胃袖状切除术在超级肥胖患者中减重效果及安全性分析[J]. 中国普通外科杂志, 2022, 31(10):1307-1315.
  XING Y, YAN W M, BAI R X. Weight loss efficacy and safety of laparoscopic sleeve gastrectomy in super obese patients[J]. J Surg Concepts Pract, 2022, 31(10):1307-1315.
[4] DE LUCA M, SHIKORA S, EISENBERG D, et al. Scientific evidence for the updated guidelines on indications for metabolic and bariatric surgery (ifso/asmbs)[J]. Surg Obes Relat Dis, 2024, 34(11):3963-4096.
[5] 中华医学会外科学分会甲状腺及代谢外科学组, 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 刘金钢, 等. 中国肥胖及代谢疾病外科治疗指南(2024版)[J]. 中国实用外科杂志, 2024, 44(8):841-849.
  Chinese Society of Thyroid and Metabolism Surgery, Chinese Society for Metabolic & Bariatric Surgery, LIU J G, et al. Chinese clinical guidelines for the surgery of obesity and metabolic disorders(2024 edition)[J]. Chin J Pract Surg, 2024, 44(8):841-849.
[6] 詹崇文, 沈奇伟, 邵怡凯, 等. 三孔法腹腔镜胃袖状切除术治疗肥胖症的疗效分析[J]. 外科理论与实践, 2023, 28(5):463-468.
  ZHAN C W, SHEN Q W, SHAO Y K, et al. Efficacy of three-port laparoscopic sleeve gastrectomy in treatment of obesity[J]. J Surg Concepts Pract, 2023, 28(5):463-468.
[7] MILONE L, STRONG V, GAGNER M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI > or =50)[J]. Obes Surg, 2005, 15(5):612-617.
[8] 朱孝成, 姚立彬. 胃袖状切除术联合双通道术的价值与存在问题[J]. 中国实用外科杂志, 2023, 43(5):523-528.
  ZHU X C, YAO L B. The value and challenges of sleeve gastrectomy with transit bipartition[J]. Chin J Pract Surg, 2023, 43(5):523-528.
[9] 姚立彬, 洪健, 侯栋升, 等. 腹腔镜袖状胃切除+双通路吻合术手术流程与技术要点[J]. 外科理论与实践, 2023, 28(2):157-161.
  YAO L B, HONG J, HOU D S, et al. Surgical process and technical points of laparoscopic sleeve gastrectomy with transit bipartition[J]. J Surg Concepts Pract, 2023, 28(2):157-161.
[10] American Diabetes Association Professional Practice Committee. Glycemic goals and hypoglycemia: standards of care in diabetes-2025[J]. Diabetes Care, 2025, 48(1Suppl 1): S128-S145.
[11] 中国高血压防治指南修订委员会, 中国高血压联盟, 中国医疗保健国际交流促进会高血压分会, 等. 中国高血压防治指南(2024年修订版)[J]. 中华高血压杂志, 2024, 32(7):603-700.
  Chinese Guideline Revision Committee for Hypertension Prevention and Control, China Hypertension League, Hypertension Branch of China International Exchange and Promotive Association for Medical and Health Care, et al. Chinese guidelines for the prevention and treatment of hypertension (2024 revision)[J]. Chin J Hypertens, 2024, 32(7):603-700.
[12] JONES R, JUNGHARD O, DENT J, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-ephageal reflux disease in primary care[J]. Aliment Pharmacol Ther, 2009, 30(10):1030-1038.
[13] BHANDARI M, PONCE DE LEON-BALLESTEROS G, KOSTA S, et al. Surgery in patients with super obesity: medium-term follow-up outcomes at a high-volume center[J]. Obesity (Silver Spring), 2019, 27(10):1591-1597.
[14] BETTENCOURT-SILVA R, NEVES J S, PEDRO J, et al. Comparative effectiveness of different bariatric procedures in super morbid obesity[J]. Obes Surg, 2019, 29(1):281-291.
[15] 李梦伊, 刘雁军, 王桂琦, 等. 大中华减重与代谢手术数据库2023年度报告[J]. 中国实用外科杂志, 2024, 44(5):552-563,570.
  LI M Y, LIU Y J, WANG G Q, et al. Greater China metabolic and bariatric surgery database registry report(2023)[J]. Chin J Pract Surg, 2024, 44(5):552-563,570.
[16] YANG N, HUA H, LIU S, et al. The current status and challenges of perioperative management of patients with a BMI of greater than or equal to 50 kg/m2 undergoing bariatric surgery in China: a multicenter cross-sectional study[J]. Int J Surg, 2024, 110(5):2577-2582.
[17] CHANG D M, LEE W J, CHEN J C, et al. Thirteen-year experience of laparoscopic sleeve gastrectomy: surgical risk, weight loss, and revision procedures[J]. Obes Surg, 2018, 28(10):2991-2997.
[18] SANTORO S, CASTRO L C, VELHOTE M C, et al. Sleeve gastrectomy with transit bipartition: a potent intervention for metabolic syndrome and obesity[J]. Ann Surg, 2012, 256(1):104-110.
[19] SANTORO S. The bipartition may be better, and not just for super obesity[J]. Surg Obes Relat Dis, 2020, 16(8):e49-e50.
[20] WANG Y, SONG Y H, CHEN J, et al. Roux-en-Y gastric bypass versus sleeve gastrectomy for super super obese and super obese: systematic review and meta-analysis of weight results, comorbidity resolution[J]. Obes Surg, 2019, 29(6):1954-1964.
[21] VERHOEFF K, MOCANU V, DANG J, et al. Five years of MBSAQIP data: characteristics, outcomes, and trends for patients with super-obesity[J]. Obes Surg, 2022, 32(2):406-415.
[22] GOMES-ROCHA S R, COSTA-PINHO A M, PAIS-NETO C C, et al. Roux-en-Y gastric bypass vs. sleeve gastrectomy in super obesity: a systematic review and meta-analysis[J]. Obes Surg, 2022, 32(1):170-185.
[23] HONG J, PARK S, MENZO E L, et al. Midterm outcomes of laparoscopic sleeve gastrectomy as a stand-alone procedure in super-obese patients[J]. Surg Obes Relat Dis, 2018, 14(3):297-303.
[24] LEMA?TRE F, LéGER P, NEDELCU M, et al. Laparoscopic sleeve gastrectomy in the South Pacific. Retrospective evaluation of 510 patients in a single institution[J]. Int J Surg, 2016,30:1-6.
[25] EISENBERG D, BELLATORRE A, BELLATORRE N. Sleeve gastrectomy as a stand-alone bariatric operation for severe, morbid, and super obesity[J]. JSLS, 2013, 17(1):63-67.
[26] 姚立彬, 于英华, 李胜利, 等. 胃袖状切除术与胃袖状切除联合双通路术术后胃食管反流病对比研究[J]. 中国实用外科杂志, 2024, 44(8):911-915.
  YAO L B, YU Y H, LI S L, et al. Comparison study on gastroesophageal reflux disease after sleeve gastrectomy and sleeve gastrectomy with transit bipartition[J]. Chin J Pract Surg, 2024, 44(8):911-915.
[27] 朱孝成, 王键, 洪健, 等. 胃袖状切除联合双通路术对预防胃袖状切除术后胃食管反流病的价值[J]. 中国实用外科杂志, 2024, 44(8):880-884.
  ZHU X C, WANG J, HONG J, et al. The value of sleeve gastrectomy with transit bipartition in preventing gastroesophageal reflux disease after sleeve gastrectomy[J]. Chin J Pract Surg, 2024, 44(8):880-884.
[28] IANNELLI A, DAINESE R, PICHE T, et al. Laparoscopic sleeve gastrectomy for morbid obesity[J]. World J Gastroenterol, 2008, 14(6):821-827.
[29] LITMANOVICH A, NETZER A, LESHEM A, et al. Long-term outcomes of one-anastomosis gastric bypass in class Ⅳ and class Ⅴ obesity: a comparative analysis with sleeve gastrectomy[J]. Obes Facts,2025:1-11.
Options
文章导航

/

〈 〉